| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.81.3.448 |
| P698 | PubMed publication ID | 9285647 |
| P2093 | author name string | Libby P | |
| Murphy C | |||
| Mach F | |||
| Fabunmi RP | |||
| Schönbeck U | |||
| Bonnefoy JY | |||
| Sukhova GK | |||
| P433 | issue | 3 | |
| P304 | page(s) | 448-454 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? | |
| P478 | volume | 81 |
| Q35150522 | 34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? |
| Q46748719 | 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. |
| Q34614796 | A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse |
| Q37765287 | A timely diagnosis of myocardial infarction. |
| Q47782268 | Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment |
| Q41005386 | Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. |
| Q34981331 | Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases? |
| Q47157522 | Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome? |
| Q43665979 | Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. |
| Q35788328 | Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions |
| Q58796774 | Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis |
| Q38972708 | Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells |
| Q35161070 | Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype |
| Q46438011 | CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes. |
| Q35538118 | CD4+ T cells in atherosclerosis |
| Q77953424 | CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts |
| Q52949259 | CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40–CD40L signalling in atherosclerosis |
| Q35793488 | CD40 ligation induces tissue factor expression in human vascular smooth muscle cells |
| Q47726341 | CD40 signaling in vascular cells: a key role in atherosclerosis? |
| Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
| Q33814059 | CD40L and Its Receptors in Atherothrombosis-An Update |
| Q33890391 | Changing concepts of atherogenesis |
| Q42725474 | Clopidogrel for the hot patient |
| Q35376658 | Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis |
| Q22010733 | Cystatin C deficiency in human atherosclerosis and aortic aneurysms |
| Q28570672 | Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 |
| Q36188431 | Cytokines and cardiovascular disease |
| Q39053492 | Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles. |
| Q36732186 | Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsies |
| Q73176775 | Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy |
| Q53688825 | Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. |
| Q34325639 | Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer |
| Q37271973 | Digging in the "soil" of the aorta to understand the growth of abdominal aortic aneurysms |
| Q35626888 | Dihydroaustrasulfone Alcohol (WA-25) Impedes Macrophage Foam Cell Formation by Regulating the Transforming Growth Factor-β1 Pathway. |
| Q36752124 | Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? |
| Q43939775 | Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome |
| Q43977294 | Endothelial cell and cAMP regulation of T-cell CD40 ligand: relevance of calcium/calmodulin-dependent kinase IV signalling |
| Q73344118 | Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions |
| Q44482796 | Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects |
| Q36367835 | Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo |
| Q37453072 | Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. |
| Q28167034 | GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention |
| Q24815894 | Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. |
| Q74298721 | Gene therapy for restenosis |
| Q39100045 | Genetic and Epigenetic Regulation of Aortic Aneurysms |
| Q44854404 | Increased soluble CD40 ligand levels in cystic fibrosis |
| Q33183763 | Induction of cyclooxygenase-2 and enhanced release of prostaglandin E(2) and I(2) in human endothelial cells by engagement of CD40. |
| Q35201247 | Inflammatory and thrombotic mechanisms in coronary atherosclerosis |
| Q35160907 | Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice |
| Q40820333 | Interaction between monocytes and vascular endothelial cells induces adrenomedullin production |
| Q42713922 | Interferon-γ: Promising therapeutic target in atherosclerosis |
| Q43122848 | Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing. |
| Q41008665 | Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. |
| Q78095861 | Macrophage accumulation within the cap of carotid atherosclerotic plaques is associated with the onset of cerebral ischemic events |
| Q35753181 | Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro |
| Q77297312 | Matrix metalloproteinases |
| Q34655385 | Matrix metalloproteinases and atherosclerotic plaque instability |
| Q35081023 | Matrix metalloproteinases and coronary artery diseases |
| Q36752100 | Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability |
| Q35088065 | Mechanisms of plaque vulnerability and rupture |
| Q38871902 | Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability |
| Q42545363 | Multimodality imaging of carotid atherosclerotic plaque: Going beyond stenosis |
| Q34132067 | New insights into atherosclerotic plaque rupture. |
| Q28579096 | OspA-CD40 dyad: ligand-receptor interaction in the translocation of neuroinvasive Borrelia across the blood-brain barrier |
| Q35585929 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
| Q42464570 | Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells |
| Q43468988 | Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis |
| Q36624223 | Present and future biochemical markers for detection of acute coronary syndrome |
| Q36452637 | Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions |
| Q34975175 | Proteomics of acute coronary syndromes |
| Q24316540 | Reduction of atherosclerosis in mice by inhibition of CD40 signalling |
| Q43812086 | Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction |
| Q52536870 | Requirement for CD154 in the progression of atherosclerosis. |
| Q36000924 | Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway |
| Q37453252 | Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response |
| Q37331764 | Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US. |
| Q46475519 | Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease |
| Q51037774 | Silent myocardial ischemia may be related to inflammatory response. |
| Q47097371 | Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial |
| Q87402529 | Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease |
| Q51498412 | Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. |
| Q37063945 | Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers |
| Q33999929 | Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome |
| Q35754623 | T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation |
| Q56804140 | The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study |
| Q47245105 | The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling |
| Q37105698 | The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial |
| Q80839013 | The effect of chronic nitric oxide synthases inhibition on regulatory proteins in rat hearts |
| Q46827546 | The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats |
| Q28508785 | The murine ortholog of matrix metalloproteinase 19: its cloning, gene organization, and expression |
| Q79291344 | The role of T-lymphocyte subpopulations in acute myocardial infarction |
| Q36600512 | The role of endometrium in endometriosis |
| Q33870602 | The role of plaque rupture and thrombosis in coronary artery disease |
| Q35169051 | The vasculopathy of Raynaud's phenomenon and scleroderma |
| Q28364526 | Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis |
| Q28344629 | Tumor necrosis factor receptor levels are associated with carotid atherosclerosis |
| Q80890474 | Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients |
| Q34514026 | Vascular inflammation as a therapeutic target for prevention of cardiovascular disease |
| Q28346458 | Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque |
| Q52620756 | Wild-type amyloid beta 1-40 peptide induces vascular smooth muscle cell death independently from matrix metalloprotease activity. |
| Q53868946 | [Interleukin-10 and coronary disease]. |
Search more.